Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Kymera Therapeutics | KYMR | 18. nov 2024 | 42.41 | +1.07 |
Kyndryl | KD | 18. nov 2024 | 28.06 | +0.50 |
Kyverna Therapeutics | KYTX | 18. nov 2024 | 4.41 | +1.26 |
L.B. Foster | FSTR | 18. nov 2024 | 25.84 | -2.45 |
L3Harris Technologies | LHX | 18. nov 2024 | 244.27 | -1.11 |
La Rosa Company | LRHC | 18. nov 2024 | 0.74 | -2.95 |
La-Z-Boy | LZB | 18. nov 2024 | 42.78 | -0.02 |
Labcorp | LH | 18. nov 2024 | 238.64 | +1.46 |
Ladder Capital | LADR | 18. nov 2024 | 11.63 | -0.09 |
Laird Superfood | LSF | 18. nov 2024 | 7.80 | -10.24 |
Lake Shore Bancorp | LSBK | 18. nov 2024 | 13.44 | -0.52 |
Lakeland Financial | LKFN | 18. nov 2024 | 73.17 | -0.07 |
Lakeland Industries | LAKE | 18. nov 2024 | 20.57 | +0.78 |
LakeShore Biopharma | LSB | 18. nov 2024 | 2.43 | -6.36 |
Lakeside Holding | LSH | 18. nov 2024 | 2.60 | -10.34 |
Lam Research | LRCX | 18. nov 2024 | 70.57 | +0.74 |
Lamar Advertising A | LAMR | 18. nov 2024 | 127.58 | +0.97 |
Lamb Weston | LW | 18. nov 2024 | 76.82 | +1.79 |
Lancaster Colony | LANC | 18. nov 2024 | 180.04 | -0.39 |
Landbridge Company | LB | 18. nov 2024 | 66.70 | -3.15 |
Landmark Bancorp | LARK | 18. nov 2024 | 22.03 | -0.11 |
Lands End | LE | 18. nov 2024 | 15.04 | -2.34 |
Landsea Homes | LSEA | 18. nov 2024 | 10.59 | +0.95 |
Landstar System | LSTR | 18. nov 2024 | 183.12 | +0.16 |
Lantern Pharma | LTRN | 18. nov 2024 | 3.16 | -10.73 |
Lantheus | LNTH | 18. nov 2024 | 76.22 | -0.79 |
Lantronix | LTRX | 18. nov 2024 | 2.76 | -2.47 |
Lanvin Group | LANV | 18. nov 2024 | 1.75 | -2.78 |
Lanzatech Global | LNZA | 18. nov 2024 | 1.00 | -7.37 |
Largecap Core Alphadex First Trust | FEX | 18. nov 2024 | 109.12 | +0.42 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.